RECKITT Benckiser has agreed to purchase US-based infant formula manufacturer Mead Johnson, with the US$17.9 billion deal said to further RB's efforts to become "a leader in consumer health".
RB also said the deal would help it expand in the rapidly growing Chinese formula market.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Feb 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Feb 17